Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells.

Candas-Green, Demet; Xie, Bowen; Huang, Jie; Fan, Ming; Wang, Aijun; Menaa, Cheikh; Zhang, Yanhong; Zhang, Lu; Jing, Di; Azghadi, Soheila; Zhou, Weibing; Liu, Lin; Jiang, Nian; Li, Tao; Gao, Tianyi; Sweeney, Colleen; Shen, Rulong; Lin, Tzu-Yin; Pan, Chong-Xian; Ozpiskin, Omer M; Woloschak, Gayle; Grdina, David J; Vaughan, Andrew T; Wang, Ji Ming; Xia, Shuli; Monjazeb, Arta M; Murphy, William J; Sun, Lun-Quan; Chen, Hong-Wu; Lam, Kit S; Weichselbaum, Ralph R; Li, Jian Jian

Candas-Green, Demet; Xie, Bowen; Huang, Jie; Fan, Ming; Wang, Aijun; Menaa, Cheikh; Zhang, Yanhong; Zhang, Lu; Jing, Di; Azghadi, Soheila; Zhou, Weibing; Liu, Lin; Jiang, Nian; Li, Tao; Gao, Tianyi; Sweeney, Colleen; Shen, Rulong; Lin, Tzu-Yin; Pan, Chong-Xian; Ozpiskin, Omer M; Woloschak, Gayle; Grdina, David J; Vaughan, Andrew T; Wang, Ji Ming; Xia, Shuli; Monjazeb, Arta M; Murphy, William J; Sun, Lun-Quan; Chen, Hong-Wu; Lam, Kit S; Weichselbaum, Ralph R; Li, Jian Jian.

Affiliation

Candas-Green D; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Xie B; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Huang J; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Fan M; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Wang A; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Menaa C; Department of Surgery, School of Medicine, University of California Davis, Sacramento, CA, 95817, USA.
Zhang Y; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Zhang L; Department of Pathology, Kaiser Permanente Medical Center Vallejo and Vacaville, Vallejo, CA, USA.
Jing D; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Azghadi S; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Zhou W; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Liu L; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Jiang N; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Li T; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Gao T; Center for Molecular Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Sweeney C; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Shen R; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Lin TY; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Pan CX; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Ozpiskin OM; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA.
Woloschak G; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.
Grdina DJ; Department of Pathology, Ohio State University, Columbus, OH, USA.
Vaughan AT; Department of Biochemistry and Molecular Medicine, University of California Davis, Sacramento, CA, USA.
Wang JM; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.
Xia S; Department of Internal Medicine, University of California Davis, Sacramento, CA, USA.
Monjazeb AM; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Murphy WJ; Department of Radiation Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Sun LQ; Department of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, USA.
Chen HW; Department of Radiation Oncology, University of California Davis, Sacramento, CA, USA.
Lam KS; NCI-Designated Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.
Weichselbaum RR; Chemoattractant Receptor and Signal Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Li JJ; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.

Nat Commun ; 11(1): 4591, 2020 09 14.

Article de En | MEDLINE | ID: mdl-32929084

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Radiotolérance / Tumeurs du sein / Récepteur ErbB-2 / Antigènes CD47 Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google